Congratulations to Quiana Ang! Quiana has been awarded her second NSERC USRA, which will enable her to continue her undergraduate research in the Pantophlet Lab over the summer, and has been accepted as a Master’s student in the Faculty of Health Sciences for Fall 2020!
Congratulations to Edarlin Bigornia, most recent undergraduate member of the Pantophlet Lab, who convocated this past week!
The Pantophlet Lab is seeking an experienced Research Assistant to support ongoing NIH- and CIHR-funded research related to HIV and flu vaccine development. Candidates will be interviewed on a rolling basis until the position is filled.
For more information, visit our Opportunities page.
Official announcement of funding through the Canada Foundation for Innovation’s John R. Evans Leaders Fund (JELF). The Hon. Kirsty Duncan, Minister of Science and Sport, made the announcement today while visiting SFU’s Burnaby Campus. Dr. Ralph Pantophlet is one of three SFU lead researchers to receive JELF funding. The Pantophlet lab will acquire a new-generation flow cytometry system, enabling high-resolution analyses of immune responses and precise recovery of immune cells, thus stimulating new vaccine and cure strategies.
[Government of Canada announcement] [PDF]
[Simon Fraser News announcement] [PDF]
SFU has entered into a license agreement for the Trianni Mouse™, a best-in-class human monoclonal antibody discovery platform. The platform incorporates a complete human antibody repertoire and will support HIV, influenza and other vaccine research and development efforts in the Pantophlet Lab.
Iva Demirova wins first place at the national final of the Sanofi Biogenius Canada (SBC) competition for her research work conducted in the Pantophlet Lab. The competition and awards ceremony took place in Ottawa on May 2 and 3, 2016. Iva is a grade 11 International Baccalaureate (IB) student from New Westminster Secondary School in BC.
Media release by SFU News of our discovery, published in Chemistry & Biology (now termed Cell Chemical Biology), of a generally harmless bacterium, Rhizobium radiobacter, that on its surface carries sugar molecules that resemble those on the surface of HIV imparted by the mammalian host cell. The discovery of these bacterial sugar molecules could help in the development of a vaccine against this still important virus.